The long-term intent is to identify targets that define specific subtypes of liver tumors and also targets that can be treated with rational approaches to improve the outcome of patients affected by liver tumors.

Dr. Graham works with a team of investigators using a combination of traditional and novel histologic, molecular and proteomic approaches. This collaborative effort evaluates liver tumors, including fibrolamellar carcinoma, hepatocellular carcinoma and hepatocellular adenomas, in order to refine the understanding and classification of liver tumors.